<!DOCTYPE html>

<html lang="en">
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title></title>
	<link rel="stylesheet" href="css/ka.css" type="text/css" />
	<link rel="stylesheet" href="css/lr.css" type="text/css" />
	<link rel="stylesheet" href="css/animate.css" type="text/css" />
	<script type="text/javascript" src="js/base.js"></script>
	<script type="text/javascript" src="js/Common.js"></script>
	<script type="text/javascript" charset="utf-8">
		
		var ANIMATION = [];
		
	</script>
</head>
<body class="popup-1-1"><div id="popup"> <p> <h3>Indication<sup>1</sup></h3> KALETRA<sup>&reg;</sup> is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. The following points should be considered when initiating therapy with KALETRA: <div class="blk_bullet">The use of other active agents with KALETRA is associated with a greater likelihood of treatment response.</div> <div class="blk_bullet">Genotypic or phenotypic testing and/or treatment history should guide the use of KALETRA. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to KALETRA.</div> <div class="blk_bullet">Once daily administration of KALETRA is not recommended for any pediatric patients.</div> <p>Please see the Important Safety Information for more about KALETRA.</p> </div></body></html>